Signals

← Signals

☆CMMB

18 in-universe funds with a nonzero position in CMMB within the trailing 4 quarters, as of 2026Q2

Catalyst Timeline merged from Insider (Form 4), 8-K and Ownership/dilution filings already on file -- not a live news feed Full insider history

DateTypeWhat happened
2025-07-25 Ownership Dilution filing by Chemomab Therapeutics Ltd. (424B5)
2024-11-15 Ownership Dilution filing by Chemomab Therapeutics Ltd. (424B5)
2024-08-09 Ownership Dilution filing by Chemomab Therapeutics Ltd. (D)
2023-06-16 8-K Item(s) 5.02
2023-06-05 8-K Item(s) 5.02, 7.01, 9.01
2023-05-11 8-K Item(s) 2.02, 9.01
2023-02-21 8-K Item(s) 8.01, 9.01
2023-02-21 8-K Item(s) 2.02, 9.01
2023-01-11 8-K Item(s) 7.01, 9.01
2023-01-03 8-K Item(s) 8.01, 9.01
2022-11-29 8-K Item(s) 9.01
2022-11-16 8-K Item(s) 8.01
2022-11-14 8-K Item(s) 5.02, 7.01, 9.01
2022-04-25 Ownership Dilution filing by Chemomab Therapeutics Ltd. (424B5)
2021-04-30 Ownership Dilution filing by Chemomab Therapeutics Ltd. (S-3)
2021-04-15 Ownership Dilution filing by Chemomab Therapeutics Ltd. (S-3)
2021-03-30 Ownership Dilution filing by Chemomab Therapeutics Ltd. (D)

Flow ranking

Rank#3807
Score / z0.000 / -0.02
Consensus4.26 over 8 funds
Momentumnot computed

Price & positioning

224 cached closes, trailing year
Drawdownnot computed
Short interestnot computed

Forensics

No XBRL fundamentals on file for this issuer — either not backfilled yet, or a financial/REIT excluded from these ratios. Not the same as clean.

Insider

No Form 4 activity on file for this ticker.

8-K events

Negative / total0 / 0
FiledFormItems
2023-06-16 8-K 5.02
2023-06-05 8-K 5.02, 7.01, 9.01
2023-05-11 8-K 2.02, 9.01
2023-02-21 8-K 8.01, 9.01
2023-02-21 8-K 2.02, 9.01
2023-01-11 8-K 7.01, 9.01
2023-01-03 8-K 8.01, 9.01
2022-11-29 8-K/A 9.01
2022-11-16 8-K 8.01
2022-11-14 8-K 5.02, 7.01, 9.01
Showing the 10 most recent.

Ownership

13D / 13G / dilution0 / 0 / 0
FiledFormFiler
2025-07-25 424B5 Chemomab Therapeutics Ltd.
2024-11-15 424B5 Chemomab Therapeutics Ltd.
2024-08-09 D Chemomab Therapeutics Ltd.
2022-04-25 424B5 Chemomab Therapeutics Ltd.
2021-04-30 S-3 Chemomab Therapeutics Ltd.
2021-04-15 S-3 Chemomab Therapeutics Ltd.
2021-03-30 D Chemomab Therapeutics Ltd.

LLM reads

Ticker Eval hasn't reached this ticker yet. It's gated to the top of the ranking, so this is an ordering artefact, not a judgement.
Quarter
Fund AUM ($M)
–
Fund Positions
–
Quarters Held
–

Fund holders

Fund ▾ Quality Q ▾ Positions ▾ Value ($M) ▾ % of Fund AUM ▾ Qtrs Held ▾ Δ 1Q ▾ Δ 2Q ▾ Δ 3Q ▾ Δ 4Q ▾
☆CITADEL ADVISORS LLC CIK 0001423053 0.482 6351 0.2 0.0% 3 +0.0 pp -0.0 pp +0.0 pp +0.0 pp
☆ADAR1 Capital Management, LLC CIK 0001940272 0.312 267 0.1 0.0% 3 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
☆KESTRA PRIVATE WEALTH SERVICES, LLC CIK 0001649451 0.633 1814 0.1 0.0% 3 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Ikarian Capital, LLC CIK 0001778253 0.063 126 0.1 0.0% 3 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆RHUMBLINE ADVISERS CIK 0001115418 0.943 4189 0.0 0.0% 4 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆XTX Topco Ltd CIK 0001828301 0.023 4087 0.0 0.0% 3 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
☆Philadelphia Investment Partners, LLC CIK 0002131511 0.329 183 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Lido Advisors, LLC CIK 0001650150 0.880 1849 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆BNP PARIBAS FINANCIAL MARKETS CIK 0001166588 0.856 5105 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
☆GAMMA Investing LLC CIK 0002010235 0.492 4173 0.0 0.0% 4 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) CIK 0000895421 0.985 8402 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
☆SBI Securities Co., Ltd. CIK 0001851815 0.645 4072 0.0 0.0% 4 +0.0 pp +0.0 pp -0.0 pp +0.0 pp
☆SPHERA FUNDS MANAGEMENT LTD. CIK 0001496201 0.149 97 0.0 0.0% 0 +0.0 pp +0.0 pp -0.1 pp +0.0 pp
☆SmartHarvest Portfolios, LLC CIK 0002066604 0.170 461 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Stonepine Capital Management, LLC CIK 0001440771 0.090 72 0.0 0.0% 0 +0.0 pp +0.0 pp -0.1 pp +0.0 pp
☆UBS Group AG (UBS) CIK 0001610520 0.954 9044 0.0 0.0% 0 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
☆SUSQUEHANNA INTERNATIONAL GROUP, LLP CIK 0001446194 0.735 6469 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆JANE STREET GROUP, LLC CIK 0001595888 0.450 5522 0.0 0.0% 0 +0.0 pp -0.0 pp -0.0 pp +0.0 pp
Value and % of AUM are this fund's own disclosed long-equity book (13F does not report true firm AUM). Positions is the fund's total position count (all tickers, not just CMMB). Qtrs Held counts distinct quarters this fund has actually held CMMB (weight > 0), across every period we've rescored. Fund AUM and Positions filters apply to the fund's whole book, not its CMMB position size. Δ columns are the percentage-point change in CMMB's weight within each fund's book vs. the trailing 1/2/3/4 quarters (2026Q1 / 2025Q4 / 2025Q3 / 2025Q2) — a fund not yet holding it that far back is treated as 0%. Only in-universe (quality-scored) funds are shown, matching the Signals-tab methodology.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status